Because of its cryptocurrency hoarding strategy, MicroStrategy (NASDAQ:MSTR) is now a big deal. It needs a new name to go along with its plus-sized game plan, so it has rebranded as Strategy. It is ...

Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while revenue slightly missed estimates.

In Q3 FY2025, it reported $35.1 billion in revenue. up 94% year-over-year, with data center revenue up 112% to $30.8 billion. Non-GAAP EPS reached $0.81 and grew 103% year-over-year. These results ...

Amazon (AMZN) stock is pulling back, after a better-than-expected fourth quarter was overshadowed by a weak forecast ...

Q4 2024 Management View CEO David Brown highlighted record performance metrics, including $1.45 adjusted earnings per diluted share for the quarter, up 26% year-over-year. Total client assets reached ...

We recently compiled a list of the Why These 15 Bank Stocks Are Skyrocketing So Far In 2025. In this article, we are going to ...

We recently compiled a list of the Why These 15 Bank Stocks Are Skyrocketing So Far In 2025. In this article, we are going to ...

Iterum Therapeutics PLC (NASDAQ:ITRM) reported its fourth-quarter 2024 financial results, revealing a narrower-than-expected loss. The company posted an actual EPS of -0.12, beating the forecasted EPS ...

We recently compiled a list of the Why These 15 Bank Stocks Are Skyrocketing So Far In 2025. In this article, we are going to ...

We recently compiled a list of the Why These 15 Bank Stocks Are Skyrocketing So Far In 2025. In this article, we are going to ...

We recently compiled a list of the Why These 15 Bank Stocks Are Skyrocketing So Far In 2025. In this article, we are going to ...

SouthernSun Asset Management, LLC, an investment management firm, released its “SouthernSun Small Cap Strategy” fourth ...